Teacher Retirement System of Texas Buys 70,464 Shares of Solventum Corporation $SOLV

Teacher Retirement System of Texas grew its stake in Solventum Corporation (NYSE:SOLV) by 105.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 137,231 shares of the company’s stock after purchasing an additional 70,464 shares during the quarter. Teacher Retirement System of Texas owned approximately 0.08% of Solventum worth $10,408,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of SOLV. Independent Franchise Partners LLP raised its position in shares of Solventum by 263.1% in the first quarter. Independent Franchise Partners LLP now owns 5,820,724 shares of the company’s stock valued at $442,608,000 after purchasing an additional 4,217,570 shares during the period. Boston Partners raised its position in shares of Solventum by 101.3% in the first quarter. Boston Partners now owns 3,361,973 shares of the company’s stock valued at $255,554,000 after purchasing an additional 1,691,565 shares during the period. Nuveen LLC bought a new position in shares of Solventum in the first quarter valued at about $35,375,000. Diamond Hill Capital Management Inc. raised its position in shares of Solventum by 139.6% in the first quarter. Diamond Hill Capital Management Inc. now owns 577,173 shares of the company’s stock valued at $43,888,000 after purchasing an additional 336,282 shares during the period. Finally, Lord Abbett & CO. LLC bought a new position in Solventum during the first quarter worth about $23,572,000.

Analysts Set New Price Targets

A number of equities analysts recently commented on SOLV shares. Morgan Stanley raised shares of Solventum from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $80.00 to $103.00 in a research report on Tuesday, July 15th. Jefferies Financial Group started coverage on shares of Solventum in a research report on Thursday, September 11th. They set a “hold” rating and a $80.00 price target on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Solventum in a research report on Wednesday, October 8th. Piper Sandler reaffirmed an “overweight” rating and set a $94.00 price target (up from $87.00) on shares of Solventum in a research report on Friday, August 8th. Finally, UBS Group started coverage on shares of Solventum in a research report on Wednesday, October 1st. They set a “neutral” rating and a $77.00 price target on the stock. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $84.89.

Solventum Trading Down 1.7%

Shares of Solventum stock opened at $69.71 on Thursday. The company has a market capitalization of $12.09 billion, a price-to-earnings ratio of 32.27, a PEG ratio of 2.88 and a beta of 0.50. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14. Solventum Corporation has a 12-month low of $60.70 and a 12-month high of $85.92. The firm’s 50-day moving average price is $72.56 and its two-hundred day moving average price is $72.30.

Solventum (NYSE:SOLV) last announced its quarterly earnings data on Thursday, August 7th. The company reported $1.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.45 by $0.24. The firm had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.56 earnings per share. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. On average, analysts forecast that Solventum Corporation will post 6.58 earnings per share for the current fiscal year.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.